Seqens Seqens

X

Find Pasireotide Diaspartate manufacturers, exporters & distributors on PharmaCompass

API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Pasireotide Diaspartate
Also known as: Dtxsid40231533, 820232-50-6
Molecular Formula
C66H80N12O17
Molecular Weight
1313.4  g/mol
InChI Key
NEEFMPSSNFRRNC-AZBBNKEOSA-N

1 2D Structure

Pasireotide Diaspartate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-aminobutanedioic acid;[(3R,6R,9R,12S,18R,20S)-9-(4-aminobutyl)-3-benzyl-12-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-phenyl-6-[(4-phenylmethoxyphenyl)methyl]-1,4,7,10,13,16-hexazabicyclo[16.3.0]henicosan-20-yl] N-(2-aminoethyl)carbamate
2.1.2 InChI
InChI=1S/C58H66N10O9.2C4H7NO4/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45;2*5-2(4(8)9)1-3(6)7/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72);2*2H,1,5H2,(H,6,7)(H,8,9)/t43-,46+,47+,48-,49+,50+,51?;2*2-/m000/s1
2.1.3 InChI Key
NEEFMPSSNFRRNC-AZBBNKEOSA-N
2.1.4 Canonical SMILES
C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN.C(C(C(=O)O)N)C(=O)O.C(C(C(=O)O)N)C(=O)O
2.1.5 Isomeric SMILES
C1[C@@H](CN2[C@H]1C(=O)NC(C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN.C([C@@H](C(=O)O)N)C(=O)O.C([C@@H](C(=O)O)N)C(=O)O
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. Dtxsid40231533

2. 820232-50-6

2.3 Create Date
2013-04-19
3 Chemical and Physical Properties
Molecular Weight 1313.4 g/mol
Molecular Formula C66H80N12O17
Hydrogen Bond Donor Count15
Hydrogen Bond Acceptor Count21
Rotatable Bond Count24
Exact Mass1312.57643913 g/mol
Monoisotopic Mass1312.57643913 g/mol
Topological Polar Surface Area482 Ų
Heavy Atom Count95
Formal Charge0
Complexity2070
Isotope Atom Count0
Defined Atom Stereocenter Count8
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
left grey arrow
right gray arrow
  • SOLUTION;SUBCUTANEOUS - EQ 0.3MG BASE/ML (EQ 0.3MG BASE/ML)
  • SOLUTION;SUBCUTANEOUS - EQ 0.6MG BASE/ML (EQ 0.6MG BASE/ML)
  • SOLUTION;SUBCUTANEOUS - EQ 0.9MG BASE/ML (EQ 0.9MG BASE/ML)
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY